Kathleen Garvey in Milwaukee, Wisconsin

Home Wisconsin Milwaukee

Kathleen Garvey has Dermatology as her primary medical specialty. Their primary office is: 2600 N Mayfair Rd in Milwaukee, Wisconsin.

They're a part of the: Forefront Dermatology medical group which has around 467 members. You can call their office at 414-771-1122 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Ohio State University College Of Homeopathic Medicine and graduated in 2005 (around 19 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Kathleen Garvey Office Phone and Directions

Kathleen Garvey
Forefront Dermatology
2600 N Mayfair Rd
Milwaukee, Wisconsin 53226
414-771-1122

Patient Ratings
Please rate your experience with Kathleen Garvey below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 414-771-1122

Enter a starting address:

Healthcare Info for Kathleen Garvey

Medical School: Ohio State University College Of Homeopathic Medicine
Graduation Year: 2005
The Primary Medical Specialty for Kathleen Garvey is listed as: Dermatology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 2668565326
NPI #: 1760505234
NPI Created On: 04/09/2007
NPI Last Updated Listed as: 09/16/2021
Primary Taxonomy Code: 207N00000X
License Number:
53289-20
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Molina Healthcare of Wisconsin, Inc.
Aspirus Arise Health Plan of Wisconsin, Inc.
Network Health Plan
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGLISH.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Injection of up to 7 skin growths
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session
New patient office or other outpatient visit, typically 20 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $80

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843621647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01